Allstate Corporation’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$553K Buy
9,911
+32
+0.3% +$1.73K 0.01% 797
2026
Q2
$543K Buy
+9,879
New +$404K 0.01% 992
2021
Q3
– Sell
-6,949
Closed -$270K – 720
2021
Q2
$270K Buy
6,949
+4
+0.1% +$157 0.01% 669
2021
Q1
$335K Hold
6,945
– – 0.01% 644
2020
Q4
$361K Buy
+6,945
New +$235K 0.01% 584

Other funds holding TGTX

Allstate Corporation's TGTX Position: Q3 2026 in Review

Allstate Corporation increased its TG Therapeutics (TGTX) stake by 0.32% in Q3 2026, buying an estimated $1.73K and bringing the position to 9,911 shares worth $553K. The position accounts for 0.01% of the portfolio, ranked #797.

Allstate Corporation first reported a position in TGTX in Q4 2020 and has held it in 5 quarters since. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Allstate Corporation held 9,911 shares of TG Therapeutics worth $553K as of Q3 2026.
  • Allstate Corporation bought 32 TG Therapeutics shares in Q3 2026, an estimated $1.73K.
  • TG Therapeutics made up 0.01% of Allstate Corporation's portfolio in Q3 2026, its #797 holding.
  • Allstate Corporation first reported a position in TG Therapeutics in Q4 2020 and has held it in 5 quarters since.
  • 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.